OSR Health grants Chairman Hwang 1.17M shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
OSR Health, Inc. (OSRH) reported that Chairman Kuk Hyoun Hwang was granted an award of 1,173,697 shares of Common Stock on October 29, 2026, issuable under the 2025 Omnibus Incentive Plan to settle accrued unpaid salary. The award price was $0.2272 per share, equal to 115% of the common stock’s volume-weighted average price for the 15 trading days ended October 28, 2026; the shares are subject to a six-month contractual lock-up from the grant date. Hwang reported 1,173,697 direct shares after the award. Shares held by BCM Europe AG were reported as 8,612,636; Bellevue Capital Management LLC held 3,123,970, and Bellevue Global Life Sciences Investors LLC held 1,332,500. Hwang may be deemed to beneficially own those entities’ shares through his control of them, but disclaims beneficial ownership except to the extent of his pecuniary interest.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | OSRH F1 | 1,173,697 | $0.2272 | $267K |
| Holding | OSRH F2 | -- | -- | -- |
| Holding | OSRH F2 | -- | -- | -- |
| Holding | OSRH F2 | -- | -- | -- |
Footnotes (2)
- F1. Represents shares of Common Stock issuable under the OSR Health, Inc. 2025 Omnibus Incentive Plan in settlement of accrued unpaid salary, at a price per share of $0.2272, equal to 115% of the volume-weighted average price of the Common Stock for the 15 trading days ended October 28, 2026. The award was approved by the Issuer's Board of Directors and Compensation Committee and is exempt under Rule 16b-3(d). The shares are subject to a six-month contractual lock-up from the grant date.
- F2. The reporting person may be deemed to beneficially own the shares held by BCM Europe AG, Bellevue Capital Management LLC and Bellevue Global Life Sciences Investors LLC by virtue of his control of such entities. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
Key Figures
Key Terms
2025 Omnibus Incentive Plan financial
volume-weighted average price financial
Rule 16b-3(d) regulatory
contractual lock-up technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.